JUN 15, 2016 7:30 AM PDT

Glycomics and glycoproteomics by CESI-MS for biomarker discovery and biopharmaceutical characterization

Sponsored by: Sciex, Sciex
Speaker
  • PhD Candidate, Center for Proteomics and Metabolomics, Leiden University Medical Center
    Biography
      Guinevere S. M. Kammeijer received a BSc degree in Biotechnology - Forensic Sciences from University of Applied Science van Hall Larenstein, Leeuwarden followed by a MSc in Analytical Chemistry at the VU University, Amsterdam. The MSc included an internship at the Center for Proteomics and Metabolomics at Leiden University Medical Center where she focused on small scale sample preparation with CESI-MS/MS.

      Currently, she is a PhD candidate at the same Center for Proteomics and Metabolomics under the supervision of Prof. Manfred Wuhrer. Her project involves exploring CESI-MS/MS for protein glycosylation analysis with a focus on the analysis of glyco-peptides, employing a porous nano-sprayer for MS coupling.

    Abstract
    Glycosylation is one of the most prevalent co- and post-translational modifications of human proteins and is known to affect the protein properties. Glycosylation is known to be involved in many different diseases. The sialic acids at the end of the glycan chain serve as a binding site for toxins, pathogens and human lectins in a linkage-specific manner having great biomarker potential. During the development and production of biopharmaceuticals glycosylation is a critical quality attribute and therefore has to be monitored. It is known that different cell culture conditions can lead to different glycoform patterns of specific proteins. Characterization of the heterogeneous character of glycoproteins in biopharmaceuticals and in biomarker discovery can be challenging and mass spectrometry (MS) based platforms are increasingly being used for the glycosylation analysis.

    In this webinar we investigate the use of CESI-MS, which is capillary electrophoresis (CE) separation combined with sheathless electrospray ionization (ESI) for biomarker discovery targeting the glycoprotein prostate specific antigen (PSA). Furthermore, in combination with a dopant enriched nitrogen gas (DEN-gas) the analysis of tryptic Fc-N-glycopeptides of a monoclonal IgG1 antibody (mAb) are explored. The precision of CESI-MS in glycosylation profiling will be compared to nano liquid chromatography (LC)–ESI–MS and matrix assisted laser desorption/ionization (MALDI)–TOF–MS. The improved repeatability and sensitivity by employing the DEN-gas will be discussed as well its application for the analysis of other glycoproteins. Moreover, CESI-MS with DEN-gas will be reviewed for the analysis of glycans after reducing-end labeling.

    Show Resources
    You May Also Like
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    DEC 09, 2020 8:00 AM PST
    DEC 09, 2020 8:00 AM PST
    Date: December 89 2020 Time: 8:00am (PST), 11:00am (EST) This talk introduces the Leica STELLARIS 8 τ-STED system where STED Nanoscopy meets Leica’s Fast Lifetime Contrast (FALCON)...
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    FEB 11, 2021 10:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    FEB 11, 2021 10:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: February 11, 2021 Time: 10:00am (PST), 1:00pm (EST) Nanobodies are single-domain antibodies derived from heavy-chain-only antibodies (HcAbs) commonly found in camelids, consisting sole...
    AUG 27, 2020 7:00 AM PDT
    C.E. CREDITS
    AUG 27, 2020 7:00 AM PDT
    DATE: August 27, 2020 TIME: 7:00am PT Novel anti-viral medications, including biologics and small molecule inhibitors, as well as serologic diagnostic tool sets are in urgent demand to fight...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    Loading Comments...
    Show Resources
    Attendees
    • See more